NASDAQ, ABMD - Abiomed Inc
We are a leading provider of medical devices in circulatory support and offer a
continuum of care in heart recovery to acute heart failure patients. Our
strategy is focused on establishing heart recovery as the goal for all acute
cardiac attacks. Our products are designed to enable the heart to rest, heal and
recover by improving blood flow and/or performing the pumping function of the
heart. We believe we are the only company with commercially available cardiac
assist devices approved for heart recovery by the Food and Drug Administration,
or FDA, and our products have been used to treat thousands of patients to date.
Our products can be used in a broad range of clinical settings, including by
heart surgeons for patients in profound shock and by interventional
cardiologists for patients who are in pre-shock or in need of prophylactic
support in the cardiac catheterization lab, or cath lab. ...
Read SEC Filing on NASDAQ.com »